Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
Jing He, Ziwei Chen, Qingfeng Xue, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 18
Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review
Cristina Aparicio, Carlos Acebal, Margarita González‐Vallinas
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 36
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis
Yiqing Cai, Liemei Lv, Tiange Lu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma
Liyuan Dai, Guangyu Fan, Tongji Xie, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
Siddesh Southekal, Sushil Kumar Shakyawar, Prachi Bajpai, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2134-2134
Open Access | Times Cited: 11
Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma
Dan Xiong, Xiaolei Wei, Weiming Huang, et al.
Aging (2024)
Open Access | Times Cited: 4
Amino Acid Metabolism-Related Gene Kynureninase (KYNU) as a Prognostic Predictor and Regulator of Diffuse Large B-Cell Lymphoma
Yu Zhang, Feng Shi, Liemei Lv, et al.
Biochemical Genetics (2025)
Closed Access
MicroRNAs in Diffuse Large B-Cell Lymphoma (DLBCL): Biomarkers with Prognostic Potential
Yu. A. Veryaskina, С. Е. Титов, Igor B. Kovynev, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1300-1300
Open Access
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Yuyang Pang, Tingxun Lu, Zijun Y. Xu‐Monette, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5493-5493
Open Access | Times Cited: 9
Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database
Hui Xu, Rong Yan, Chunmei Ye, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
Xiaodie Mu, Aihua Wu, Huiyue Hu, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 2061-2075
Open Access | Times Cited: 7
Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study
Wanli Wang, Hong-Jie Jiang, Ze-Liang Shen, et al.
Archives of Oral Biology (2024) Vol. 163, pp. 105982-105982
Closed Access | Times Cited: 2
SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
Yi Wang, Xue Chen, Yun Li, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics
Le Zhang, Xiaoling Yan, Yahong Wang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37374-e37374
Open Access | Times Cited: 2
Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma
Qiang Guo, Chuangyan Wu, Ni Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma
ChaoFeng Zhang, Qi Lin, Chuntuan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
A novel angiogenesis-related scoring model predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma
Yu Liu, Jinhua Wang, Xiaochen Shen, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3781-3797
Closed Access | Times Cited: 5
A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
Yajiao Liu, Sheng Li, Haiying Hua, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 651-666
Open Access | Times Cited: 5
A Novel Lipid Metabolism and Endoplasmic Reticulum Stress-Related Risk Model for Predicting Immune Infiltration and Prognosis in Colorectal Cancer
Hao-Ran Jin, Bihan Xia, Jin Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13854-13854
Open Access | Times Cited: 5
Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma
Jinghua Wang, Yanjun Wang, Li Wan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
Yuxin Wang, Xueshuai Wan, Shunda Du
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review
Jelena Jelicic, Thomas Stauffer Larsen, Bosko Andjelic, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104293-104293
Open Access | Times Cited: 1
DLD is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients
Can Chen, Dandan Kang, Zhenzhen Chen, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1696-1708
Open Access | Times Cited: 1
Artificial intelligence-based prognostic model accurately predicts the survival of patients with diffuse large B-cell lymphomas: analysis of a large cohort in China
Huilin Peng, M. Su, Xiang Guo, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma
Mengqing Chen, Xue Wang, Wenjun Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top